![Change in Albuminuria and GFR as End Points for Clinical Trials in Early Stages of CKD: A Scientific Workshop Sponsored by the National Kidney Foundation in Collaboration With the US Food and Change in Albuminuria and GFR as End Points for Clinical Trials in Early Stages of CKD: A Scientific Workshop Sponsored by the National Kidney Foundation in Collaboration With the US Food and](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/1320e154-758f-4de9-bce8-7de434c32cd3/gr1.jpg)
Change in Albuminuria and GFR as End Points for Clinical Trials in Early Stages of CKD: A Scientific Workshop Sponsored by the National Kidney Foundation in Collaboration With the US Food and
![Implementing the European Renal Best Practice Guidelines suggests that prediction equations work well to differentiate risk of end-stage renal disease vs. death in older patients with low estimated glomerular filtration rate - Implementing the European Renal Best Practice Guidelines suggests that prediction equations work well to differentiate risk of end-stage renal disease vs. death in older patients with low estimated glomerular filtration rate -](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/4203a004-74b3-42ab-81c2-0add1c9bd061/fx1.jpg)
Implementing the European Renal Best Practice Guidelines suggests that prediction equations work well to differentiate risk of end-stage renal disease vs. death in older patients with low estimated glomerular filtration rate -
![The prevalence of chronic kidney disease in Iceland according to KDIGO criteria and age-adapted estimated glomerular filtration rate thresholds - Kidney International The prevalence of chronic kidney disease in Iceland according to KDIGO criteria and age-adapted estimated glomerular filtration rate thresholds - Kidney International](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/91a9cd79-623e-4a03-8b9b-7da31a265ced/fx1.jpg)
The prevalence of chronic kidney disease in Iceland according to KDIGO criteria and age-adapted estimated glomerular filtration rate thresholds - Kidney International
![Prevalence of chronic kidney disease by GFR and albuminuria (based on... | Download Scientific Diagram Prevalence of chronic kidney disease by GFR and albuminuria (based on... | Download Scientific Diagram](https://www.researchgate.net/publication/331812069/figure/fig2/AS:962851434938373@1606573079628/Prevalence-of-chronic-kidney-disease-by-GFR-and-albuminuria-based-on-22-Green-low.png)
Prevalence of chronic kidney disease by GFR and albuminuria (based on... | Download Scientific Diagram
![Effect of dapagliflozin on urinary albumin excretion in patients with chronic kidney disease with and without type 2 diabetes: a prespecified analysis from the DAPA-CKD trial - The Lancet Diabetes & Endocrinology Effect of dapagliflozin on urinary albumin excretion in patients with chronic kidney disease with and without type 2 diabetes: a prespecified analysis from the DAPA-CKD trial - The Lancet Diabetes & Endocrinology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/43e31605-2d18-4b3f-b628-28ccfffda1c5/gr1.jpg)
Effect of dapagliflozin on urinary albumin excretion in patients with chronic kidney disease with and without type 2 diabetes: a prespecified analysis from the DAPA-CKD trial - The Lancet Diabetes & Endocrinology
![Kinetische glomeruläre Filtrationsrate - Wegweiser aus dem Formelwald - Trillium GmbH Medizinischer Fachverlag Kinetische glomeruläre Filtrationsrate - Wegweiser aus dem Formelwald - Trillium GmbH Medizinischer Fachverlag](https://www.trillium.de/fileadmin/user_upload/Keller_Abb1_Formeln-kinetischen-GFR.jpg)
Kinetische glomeruläre Filtrationsrate - Wegweiser aus dem Formelwald - Trillium GmbH Medizinischer Fachverlag
![Simultaneous glomerular filtration rate determination using inulin, iohexol, and 99mTc-DTPA demonstrates the need for customized measurement protocols - Kidney International Simultaneous glomerular filtration rate determination using inulin, iohexol, and 99mTc-DTPA demonstrates the need for customized measurement protocols - Kidney International](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/efc48438-28cb-4663-9a04-67b2d7e52c68/fx1.jpg)